
Sign up to save your podcasts
Or


Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.
By Kevin Folta4.8
273273 ratings
Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.

32,246 Listeners

6,881 Listeners

30,609 Listeners

43,687 Listeners

9,238 Listeners

4,022 Listeners

2,053 Listeners

599 Listeners

756 Listeners

3,648 Listeners

12,130 Listeners

818 Listeners

6,467 Listeners

113,121 Listeners

4,167 Listeners